Anticancer half-sandwich Ir(III) complex and its interaction with various biomolecules and their mixtures - a case study with ascorbic acid
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F22%3A73613716" target="_blank" >RIV/61989592:15310/22:73613716 - isvavai.cz</a>
Výsledek na webu
<a href="https://pubs.rsc.org/en/content/articlehtml/2022/qi/d2qi00535b" target="_blank" >https://pubs.rsc.org/en/content/articlehtml/2022/qi/d2qi00535b</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d2qi00535b" target="_blank" >10.1039/d2qi00535b</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Anticancer half-sandwich Ir(III) complex and its interaction with various biomolecules and their mixtures - a case study with ascorbic acid
Popis výsledku v původním jazyce
The extent of interactions with various biomolecules is a crucial feature of newly developed metallodrugs, worthy of thorough investigation, as its understanding helps uncover the fate of these xenobiotics in the physiological environment. In this work, promisingly cytotoxic half-sandwich complexes [Ru(eta(6)-pcym)Cl(L-1)]PF6 (1), [Ir(eta(5)-Cp*)Cl(L-1)]PF6 (2) and [Ir(eta(5)-Cp*)Cl(L-2)]PF6 (3), with 2-{n-[(E)-phenyldiazenyl]pyridin-2-yl)-1H-benzimidazole as a bidentate N-donor azo ligand (n = 5 for L-1 and 6 for L-2; pcym = p-cymene, Cp* = pentamethylcyclopentadienyl), were subjected to an extensive and detailed study of interactions with a plethora of extra- and intracellular biologically relevant molecules. For the first time in the field of anticancer half-sandwich complexes, mixtures of 3 with ascorbic acid (ASA) and its combinations with reduced glutathione (GSH) and/or reduced nicotinamide adenine dinucleotide (NADH) were studied. Complex 3 undergoes azo bond reduction when mixed with NADH or ASA, which oxidizes to NAD(+) or dehydroascorbate (DHA), respectively. Intriguingly, the presence of the natural antioxidant ASA has a relevant prooxidative impact on GSH, which is connected with ASA recovery from DHA. Although the azo bond of L-2 involved in 3 seems to be the reaction centre for the dehydrogenation reactions of the biomolecules, L-2 by itself is a negligible oxidant and thus complexation in 3 represents a necessary prerequisite for the redox reactions.
Název v anglickém jazyce
Anticancer half-sandwich Ir(III) complex and its interaction with various biomolecules and their mixtures - a case study with ascorbic acid
Popis výsledku anglicky
The extent of interactions with various biomolecules is a crucial feature of newly developed metallodrugs, worthy of thorough investigation, as its understanding helps uncover the fate of these xenobiotics in the physiological environment. In this work, promisingly cytotoxic half-sandwich complexes [Ru(eta(6)-pcym)Cl(L-1)]PF6 (1), [Ir(eta(5)-Cp*)Cl(L-1)]PF6 (2) and [Ir(eta(5)-Cp*)Cl(L-2)]PF6 (3), with 2-{n-[(E)-phenyldiazenyl]pyridin-2-yl)-1H-benzimidazole as a bidentate N-donor azo ligand (n = 5 for L-1 and 6 for L-2; pcym = p-cymene, Cp* = pentamethylcyclopentadienyl), were subjected to an extensive and detailed study of interactions with a plethora of extra- and intracellular biologically relevant molecules. For the first time in the field of anticancer half-sandwich complexes, mixtures of 3 with ascorbic acid (ASA) and its combinations with reduced glutathione (GSH) and/or reduced nicotinamide adenine dinucleotide (NADH) were studied. Complex 3 undergoes azo bond reduction when mixed with NADH or ASA, which oxidizes to NAD(+) or dehydroascorbate (DHA), respectively. Intriguingly, the presence of the natural antioxidant ASA has a relevant prooxidative impact on GSH, which is connected with ASA recovery from DHA. Although the azo bond of L-2 involved in 3 seems to be the reaction centre for the dehydrogenation reactions of the biomolecules, L-2 by itself is a negligible oxidant and thus complexation in 3 represents a necessary prerequisite for the redox reactions.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10402 - Inorganic and nuclear chemistry
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Inorganic Chemistry Frontiers
ISSN
2052-1545
e-ISSN
2052-1553
Svazek periodika
9
Číslo periodika v rámci svazku
15
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
13
Strana od-do
3758-3770
Kód UT WoS článku
000813183200001
EID výsledku v databázi Scopus
2-s2.0-85132533763